CD44 and cancer: In this study, we provide novel evidence to the ability of the TME to regulate intra-tumoral heterogeneity in Luminal-A tumors and to enrich the cancer cells with two sub-populations: CD44+/CD24low/− cells with a stem-like phenotype and CD44+/β1+ cells that express high levels of adhesion molecules.